- Land USA
Aktuelle Berichte
News Funktionen
Weitere Funktionen
26 Juni 2024
Amphastar Pharmaceuticals, Inc.
June 2024 Corporate Presentation
6 Juni 2024
Amphastar Pharmaceuticals, Inc.
Presentation
15 Mai 2024
Amphastar Pharmaceuticals, Inc.
BOFA Presentation
10 Mai 2024
Amphastar Pharmaceuticals, Inc.
Q1 24 10-Q
8 Mai 2024
Amphastar Pharmaceuticals, Inc.
Q1 2024 Earnings Presentation
10 April 2024
Amphastar Pharmaceuticals, Inc.
Needham Presentation
9 April 2024
Amphastar Pharmaceuticals, Inc.
Needham Presentation
1 März 2024
Amphastar Pharmaceuticals, Inc.
Q4 2023 10K
29 Februar 2024
Amphastar Pharmaceuticals, Inc.
2023 Annual Report
10 Januar 2024
Amphastar Pharmaceuticals, Inc.
JPM Presentation
8 November 2023
Amphastar Pharmaceuticals, Inc.
Q3 2023 10Q
15 September 2023
Amphastar Pharmaceuticals, Inc.
September 2023 Corporate Presentation
9 August 2023
Amphastar Pharmaceuticals, Inc.
Q2
8 Juni 2023
Amphastar Pharmaceuticals, Inc.
Jefferies Presentation
9 Mai 2023
Amphastar Pharmaceuticals, Inc.
10Q Q1 2023
24 April 2023
Amphastar Pharmaceuticals, Inc.
Business Update Presentation
2 März 2023
Amphastar Pharmaceuticals, Inc.
10K 2022
1 März 2023
Amphastar Pharmaceuticals, Inc.
Audit Committee Charter
Amphastar Pharmaceuticals, Inc.
Nominating and Corporate Governance Committee Charter
Amphastar Pharmaceuticals, Inc.
Compensation Committee Charter
28 Februar 2023
Amphastar Pharmaceuticals, Inc.
10K Q4 22
13 Januar 2023
Amphastar Pharmaceuticals, Inc.
Compliance Declaration
30 November 2022
Amphastar Pharmaceuticals, Inc.
Piper Sandler Presentation
16 November 2022
Amphastar Pharmaceuticals, Inc.
Jefferies Presentation
8 November 2022
Amphastar Pharmaceuticals, Inc.
10Q Q3 22
7 September 2022
Amphastar Pharmaceuticals, Inc.
Wells Fargo Presentation 9.7.22
9 August 2022
Amphastar Pharmaceuticals, Inc.
10Q Q2 22
8 Juni 2022
Amphastar Pharmaceuticals, Inc.
Jefferies Healthcare Conference Presentation
10 Mai 2022
Amphastar Pharmaceuticals, Inc.
Q1 2022 10Q
12 April 2022
Amphastar Pharmaceuticals, Inc.
21st Annual Needham Virtual Healthcare Conference Presentation
Aktuelle News
News Funktionen
Weitere Funktionen
4 Juni 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
3 Juni 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
22 Mai 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
9 Mai 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
8 Mai 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
30 April 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024